Benitec Biopharma PEG Ratio

Benitec Biopharma posts a PEG ratio of 54.4. That is above the sector sector average of 3.69. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a PEG ratio near 3.69 is typical. Benitec Biopharma's 54.4 is higher that level. That is roughly 1372.7% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Benitec Biopharma's PEG ratio of 54.4 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for BNTC's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 3.69), and (3) consistency with growth and profitability. This page covers the first two; Benitec Biopharma's other metric pages and overview cover the third.